2 completed, 2 terminated, 2 unknown. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Terminated 2, Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Helping Behavior: new trials by email Literature Review of Helping Behavior trials Research Report on Helping Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation Triptorelin 3.75 MG Injection, Transvaginal oocyte retrieval, Triptorelin Injection - Breast Cancer Female | Phase 1 / Phase 2 | Unknown | Universitair Ziekenhuis Brussel | 30 | 2022-11-01 | 2023-05-18 |
| A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age Recombinant human luteinizing hormone (rhLH), Recombinant follicle-stimulating hormone (rFSH) - Infertility, Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 76 | 2008-11-01 | 2014-02-13 |
| Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) Immunoablation and Autologous Hematopoietic Stem Cell Transplantation - Systemic Lupus Erythematosus | Phase 2 | Unknown | Charite University, Berlin, Germany | 30 | 2008-08-01 | 2017-03-20 |
| A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age r-hLH + r-hFSH, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG) - Infertility, Ovulation Induction | Phase 2 | Terminated | Merck KGaA, Darmstadt, Germany | 93 | 2007-11-01 | 2014-02-27 |
| Lutropin Alfa in Women at Risk of Poor Response r-FSH, r-hLH, Analogous GnRH antagonist - Ovarian Stimulation | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 58 | 2005-12-07 | 2018-08-28 |
| A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve Recombinant human follicle stimulating hormone (r-hFSH), Recombinant human luteinizing hormone (r-hLH) - Infertility, Ovulation Induction | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 131 | 2005-01-10 | 2018-03-27 |
Infertility (3) · Lupus Erythematosus, Systemic (1)
Behavior (6) · Social Behavior (6) · Genital Diseases (3) · Urogenital Diseases (3) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Skin and Connective Tissue Diseases (1)
Luteinizing Hormone, beta Subunit (4) · Glycoprotein Hormones, alpha Subunit (2) · cetrorelix (2) · follitropin alfa (2) · Chorionic Gonadotropin (1) · Injections (1) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1) · Progesterone (1) · Triptorelin Pamoate (1)
Merck KGaA, Darmstadt, Germany (4) · Charite University, Berlin, Germany (1) · Universitair Ziekenhuis Brussel (1)
Spain (4) · Belgium (1) · Germany (1)
Falk Hiepe, Prof (1) · Michel De Vos, MD PhD (1)
2005 (1), 2008 (1)